TSHA vs. OLMA
Compare and contrast key facts about Taysha Gene Therapies, Inc. (TSHA) and Olema Pharmaceuticals, Inc. (OLMA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TSHA or OLMA.
Key characteristics
| TSHA | OLMA | |
|---|---|---|
| YTD Return | -24.29% | -15.47% |
| 1Y Return | -45.97% | -28.51% |
| 3Y Return (Ann) | -55.87% | -24.91% |
| Sharpe Ratio | -0.42 | -0.33 |
| Sortino Ratio | -0.07 | -0.01 |
| Omega Ratio | 0.99 | 1.00 |
| Calmar Ratio | -0.46 | -0.29 |
| Martin Ratio | -1.21 | -0.84 |
| Ulcer Index | 36.36% | 29.26% |
| Daily Std Dev | 104.25% | 75.46% |
| Max Drawdown | -98.14% | -96.26% |
| Current Drawdown | -95.78% | -78.24% |
Fundamentals
| TSHA | OLMA | |
|---|---|---|
| Market Cap | $274.62M | $679.18M |
| EPS | -$0.49 | -$2.04 |
| Total Revenue (TTM) | $8.13M | $1.88M |
| Gross Profit (TTM) | $7.14M | $1.61M |
| EBITDA (TTM) | -$60.44M | -$98.02M |
Correlation
The correlation between TSHA and OLMA is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TSHA vs. OLMA - Performance Comparison
In the year-to-date period, TSHA achieves a -24.29% return, which is significantly lower than OLMA's -15.47% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TSHA vs. OLMA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Taysha Gene Therapies, Inc. (TSHA) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TSHA vs. OLMA - Dividend Comparison
Neither TSHA nor OLMA has paid dividends to shareholders.
Drawdowns
TSHA vs. OLMA - Drawdown Comparison
The maximum TSHA drawdown since its inception was -98.14%, roughly equal to the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for TSHA and OLMA. For additional features, visit the drawdowns tool.
Volatility
TSHA vs. OLMA - Volatility Comparison
Taysha Gene Therapies, Inc. (TSHA) has a higher volatility of 19.49% compared to Olema Pharmaceuticals, Inc. (OLMA) at 11.36%. This indicates that TSHA's price experiences larger fluctuations and is considered to be riskier than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TSHA vs. OLMA - Financials Comparison
This section allows you to compare key financial metrics between Taysha Gene Therapies, Inc. and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities